Back

Panel discussion.

28 August 2017 (12:09 - 12:12)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 2 Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

17 More presentations in this session

Presentation thumbnail
SPYRAL HTN OFF-MED Study
Professor M. Boehm (Homburg, DE)
Slides Video
Presentation thumbnail
Discussant review: SPYRAL HTN OFF-MED Study
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Panel discussion.
Presentation thumbnail
Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor M. Ezekowitz (Philadelphia, US)
Slides Video
Presentation thumbnail
Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Professor J. Nielsen (Aarhus, DK)
Slides Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 2

The Event

Event poster

ESC Congress 2017

28 August 2017 12:09 CET
You may be interested in
thumbnail
Congress Presentation
Panel discussion - Dan-NICAD-2 .
28 August 2022
thumbnail
Congress Presentation
Physical activity referral systems: maintaining exercise long term - panel discussion.
27 August 2022
thumbnail
Congress Presentation
Panel discussion
30 August 2025
thumbnail
Congress Presentation
Masterclass in scientific writing (I): expert insights and practical tips - panel discussion
11 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources